Frederick Nchang Cho

Frederick Nchang Cho


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2021 in Journal of Parasitology Research
Verified
Journal Article
Open access
PDF file
PFPaulette Ngum Fru
Paulette Ngum Fru
FCFrederick Nchang Cho
Frederick Nchang Cho
ATAndrew N. Tassang
Andrew N. Tassang
CFCelestina Neh Fru
Celestina Neh Fru
PFPeter Nde Fon
Peter Nde Fon
AEAlbert Same Ekobo
Albert Same Ekobo
Introduction. Malaria is and remains a serious health concern in Africa. In Cameroon, where malaria is endemic and a major public health problem, the major control measure put in place is the use of long-lasting insecticidal nets (LLINs). In the Tiko Health District (THD), the challenges have been to assess and to evaluate the ownership and utilisation of LLINs. This study sought to assess the ownership and utilisation rates of LLINs in the THD. Methodology. A cross-sectional survey involving 418 households was conducted in four health areas in the THD. A structured questionnaire was used to collect data on LLIN ownership and utilisation as well as sociodemographic characteristics. Results. The ownership of at least one LLIN per household, coverage, and accessibility were, respectively, 89, 56.2, and 66.3, while installing LLINs on all beds in the household, sleeping under LLINs the previous night (SULPN), and universal utilisation were 72, 24.9, and 14.1, respectively. Factors significantly associated with the ownership of at least one LLIN per household were respondents age and gender. Heat (21.1) and forgetfulness (6.5) were the main reasons postulated for irregular utilisation of LLINs. Conclusion. The ownership LLINs failed to guarantee utilisation and definitely effective control of malaria in the THD, as expected. Continuous and appropriate use of LLINs is indispensable, in addition to periodic sanitation, booster campaigns of LLIN distribution, and evaluation research for effective prevention and control of malaria.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JEJude Eteneneng Enoh
Jude Eteneneng Enoh
FCFrederick Nchang Cho
Frederick Nchang Cho
FMF. Pascal T Manfo
F. Pascal T Manfo
SASimon Eyongabane Ako
Simon Eyongabane Ako
EAEric Achidi Akum
Eric Achidi Akum
Hepatotoxicity is historically the 3rd most common reason for drug withdrawal and toxicity‐related discontinuation of treatment. This study was aimed at determining the incidence and the onset of hepatotoxicity and at evaluating the relationship of some risk factors for hepatotoxicity among Human Immunodeficiency Virus‐ (HIV‐) positive, tuberculosis (TB), and HIV/TB patients on treatment. This was a prospective follow‐up study involving 125 participants from the HIV/AIDS and TB treatment centres in three hospitals in Fako Division of Cameroon. These TB and HIV patients were initiated on RHEZ (R = Rifampicin, H = Isoniazid, E = Ethambutol, and P = Pyrazinamide) and TELE (efavirenz/tenofovir/lamivudine), respectively, and followed up for 12 weeks between September 2018 and November 2019. The levels of liver enzymes (transaminases, gamma‐glutamyltransferase, alkaline phosphatase, and unconjugated/total bilirubin) were measured spectrophotometrically using serum. The Chi‐squared (χ2) test was used to assess the association between risk factors and hepatotoxicity, while the Kaplan‐Meier survival analysis with the log‐rank test was used to determine the occurrence of hepatotoxicity in the different groups. We followed the general study population for a total person time of 6580 person‐days, with an incidence rate and cumulative incidence of 8 cases per 1000 person‐days (53/6580 person‐days) and 42.4% (53/125), respectively (95% confidence interval), recorded after 12 weeks of follow‐up of all the participants. The onset of hepatotoxicity in the total study population was statistically significant (χ2 = 9.5334; p = 0.022979; CI = 95%), with the majority observed at week eight of follow‐up. Also, the incidence rate and cumulative incidence of hepatotoxicity with respect to HIV/AIDS, TB, and HIV/TB patients, respectively, at 95% confidence interval were: 8 cases per 1000 person‐days (32/3843 person‐days) and 32/76 (42.1%), 6 cases per 1000 person‐days (12/1932 person‐days) and 12/32 (37.5%), and 11 cases per 1000 person‐days (9/805 person‐days) and 9/17 (52.9%). This study shows that the incidence rate and cumulative incidence of hepatotoxicity in HIV/AIDS, TB, and HIV/TB patients on treatment were high in Fako Division, Cameroon. Also, it is very important to check these patients’ liver function especially within the first 12 weeks of treatment.

24 September 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
MNMarie Clarie Fien Ndim
Marie Clarie Fien Ndim
FCFrederick Nchang Cho
Frederick Nchang Cho
DTDiane Zinkeng Tongwa
Diane Zinkeng Tongwa
SKSih Ashley Kum
Sih Ashley Kum
CTChristabel Afor Tatah
Christabel Afor Tatah
ATAndrew N. Tassang
Andrew N. Tassang
Despite national efforts to scale up the human immunodeficiency virus (HIV) testing in Cameroon, many youths still remain untested. Understanding their knowledge, attitudes, stigma perceptions, and practices (KASP) towards HIV testing is vital for improving uptake. This study aimed to assess HIV-related KASP and identify barriers and facilitators to among youths aged 18–35 years in Kumba, Cameroon. A community-based cross-sectional study was conducted from February to April 2025 among 632 youths selected through a multistage sampling technique, stratified by municipalities and neighbourhoods across Kumba. Data were collected using a structured, pre-tested questionnaire. Descriptive statistics were used to summarise the sociodemographic data and KASP scores. Binary and ordinal logistic regression analyses were used to identify factors associated with HIV testing. Out of the 632 participants, 528 (83.5%) demonstrated moderate knowledge of HIV testing, while 33 (3.6%) had high knowledge. Positive attitudes toward HIV testing were observed in 128 (20.3%) participants. Fear of receiving a positive result 222 (35.1%) and anticipated stigma 107 (16.9%) were cited as barriers to testing. Youths with no sexual partners were significantly more likely to have good knowledge (OR 2.98, 95% CI: 1.53–5.78, p = 0.001), positive attitudes (OR 3.15, 95% CI: 1.81–5.47, p < 0.001), and testing practices (OR 7.62, 95% CI: 4.05–14.32, p < 0.001). While stigma was associated with lower testing uptake, sociodemographic factors such as gender, education, and religion were not significantly associated with testing behaviour. Although knowledge and attitudes towards HIV were generally positive, substantial gaps remain in testing uptake. Fear of a positive result and stigma were key barriers cited by one-third and one-sixth of the participants, respectively. This highlights the need for targeted community-based interventions, including peer-led education programmes, stigma-reduction campaigns, and youth-friendly testing services. Integration of HIV education into youth outreach and health programmes is recommended. As a cross-sectional study, causal relationships could not be established.. - This study assessed HIV-related knowledge, attitudes, and testing practices among youths aged 18–35 years in Kumba, Cameroon. - Although general knowledge about HIV was high, misconceptions remained, and nearly one-third of the participants had never been tested for HIV. - HIV-related stigma, fear of positive results, and lack of youth-friendly services were major barriers to testing, underscoring the need for targeted awareness, improved counselling, and community-level interventions to promote regular voluntary HIV testing among youths in similar urban-rural communities.

1 March 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
SPSrinivas Pallerla
Srinivas Pallerla
Darrel Ornelle ELION ASSIANADarrel Ornelle ELION ASSIANA
Darrel Ornelle ELION ASSIANA
LLLe Thi Kieu Linh
Le Thi Kieu Linh
FCFrederick Nchang Cho
Frederick Nchang Cho
CMChristian Meyer
Christian Meyer
Thirumalaisamy P. VelavanThirumalaisamy P. Velavan
Thirumalaisamy P. Velavan
HIV-infection, tuberculosis and malaria are the big three communicable diseases that plague sub-Saharan Africa. If these diseases occur as co-morbidities they require polypharmacy, which may lead to severe drug-drug-gene interactions and variation in adverse drug reactions, but also in treatment outcomes. Polymorphisms in genes encoding drug-metabolizing enzymes are the major cause of these variations, but such polymorphisms may support the prediction of drug efficacy and toxicity. There is little information on allele frequencies of pharmacogenetic variants of enzymes involved in the metabolism of drugs used to treat HIV-infection, TB and malaria in the Republic of Congo (ROC). The aim of this study was therefore to investigate the occurrence and allele frequencies of 32 pharmacogenetic variants localized in absorption distribution, metabolism and excretion (ADME) and non-ADME genes and to compare the frequencies with population data of Africans and non-Africans derived from the 1000 Genomes Project. We found significant differences in the allele frequencies of many of the variants when comparing the findings from ROC with those of non-African populations. On the other hand, only a few variants showed significant differences in their allele frequencies when comparing ROC with other African populations. In addition, considerable differences in the allele frequencies of the pharmacogenetic variants among the African populations were observed. The findings contribute to the understanding of pharmacogenetic variants involved in the metabolism of drugs used to treat HIV-infection, TB and malaria in ROC and their diversity in different populations. Such knowledge helps to predict drug efficacy, toxicity and ADRs and to inform individual and population-based decisions.

20 January 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FCFrederick Nchang Cho
Frederick Nchang Cho
YNYayah Emerencia Ngah
Yayah Emerencia Ngah
ATAndrew N Tassang
Andrew N Tassang
CFCelestina Neh Fru
Celestina Neh Fru
PEPeter Canisius Kuku Elad
Peter Canisius Kuku Elad
PFPaulette Ngum Fru
Paulette Ngum Fru
Introduction: This study aimed to establish pre-/post Coronavirus Disease 2019 (COVID-19) diagnosis/treatment symptoms, ownership/utilisation of face masks (FMs), as well as vaccine hesitancy (VH) amongst patients recovering from COVID-19.Methods: A cross-sectional survey was conducted from April - October 2021. Data was collected with structured self-administered questionnaires. Multinomial regression was used to determine associations between ownership/utilisation of FMs with respondents’ characteristics.Results: Unproductive cough and fatigue were prevalent before and after treatment. Pre-/Post COVID-19 symptoms severity ranged from mild to moderate. There was a COVID-19 VH rate of 492 (74%). The prevalence of FM ownership and utilisation were, respectively, 613 (92.2%) and 271 (40.8%). One main factor was associated with FM ownership; respondent’s sex (p; 5.5x10-2, OR; 0.5, 95%C.I; 0.3 – 1.0). The main reasons for irregular utilisation were; inability to be consistent, only used outdoors, and boredom.Conclusion: The treatment of COVID-19 does not mean immediate recovery as mild to moderate grade severity still persists. Face mask availability and ownership does not mean appreciable utilisation. This study advocates for an intensification of COVID-19 preventive practices, as well as elaborate education on the importance of vaccination.

1 February 2021 in Journal of Parasitology Research
Verified
Journal Article
Open access
PDF file
FCFrederick Nchang Cho
Frederick Nchang Cho
HNHumphrey Ngala Ngala
Humphrey Ngala Ngala
RBRanibell Tung Bongazi
Ranibell Tung Bongazi
RKRogers Sanga Kinsam
Rogers Sanga Kinsam
BTBeltha Tahnteng Tata
Beltha Tahnteng Tata
PJPatrick Kofon Jokwi
Patrick Kofon Jokwi
Introduction. Soil-transmitted helminths (STH) remain a public health problem worldwide especially in low-income countries. Soil-transmitted helminths are known to affect both growth and haemoglobin levels. In this study, we determine the prevalence of intestinal parasites and explored its association with anaemia in school-aged children (SAC). Methodology. A cross-sectional study was carried out amongst pupils selected from 18 primary schools in four communities of the North West Region. Stool samples were examined using direct wet mount and formol-ether concentration techniques, while finger prick was performed for the measurement of haemoglobin with a haemoglobinometer. Results. The results showed significant variation of STHs, intestinal protozoan prevalence, and anaemia between age, sex, and communities. The prevalence of Ascaris lumbricoides, Trichuris trichiura, and hookworms was 15.1%, 0.8%, and 2%, respectively, with an overall STH prevalence of 18.3% across the four communities. Soil-transmitted helminths were more prevalent in Mbessa (30.2%) in comparison to Nkor (26.7%), Djottin (17.5%), and Kumbo (9.6%) communities. The prevalence of Entamoeba histolytica/dispar was 25.4% and Giardia duodenalis (6.9%), with an overall intestinal protozoa prevalence of 31% across the four communities. The prevalence of anaemia in the study population was 23.1%. Conclusion. Soil-transmitted helminths, intestinal protozoan infections, and anaemia are prevalent in the study area. Anaemia was observed to be associated with STH, intestinal protozoa, and the communities under study. This study recommends continuous deworming and health education on personal sanitation and environmental sanitation.